Fundz

Virtue Diagnostics Closes $100 Million Series B Funding

PRIVATEJan 06, 2022

Amount Raised

$100 Million

Round Type

Series B

ShanghaiHealth CareApps

Description

Virtue Diagnostics, an innovative IVD company, has just announced closing US$100 million in Series B funding. Virtue Diagnostics, founded in 2019, is focused on clinical tests for China and emerging markets. Sequoia China and Morningside Ventures jointly led the investment round with ORIZA Holdings. Existing investors Lilly Asia Ventures and PerkinElmer Ventures participated while HAOYUE Capital was the exclusive financial advisor.

Quick answer

Virtue Diagnostics raised $100 Million in a Series B round, dated January 6, 2022. Virtue Diagnostics is based in Shanghai, Shanghai, China.

How much did Virtue Diagnostics raise?
Virtue Diagnostics raised $100 Million in a Series B round on January 6, 2022.
What does Virtue Diagnostics do?
Virtue Diagnostics is an innovative IVD company focused on infectious disease, cancer, and chronic diseases.Our goal is to utilize our diverse technology platforms to provide clinical solutions for patients at all..
Where is Virtue Diagnostics based and how big is it?
Virtue Diagnostics is based in Shanghai, Shanghai, China.

Source: Fundz verified event record.

Who else raised in Apps and Health Care around the same time

Companies in the same sectors as Virtue Diagnostics that raised within 45 days of this round, from Fundz verified event records.

  • Vangst raised $19M (Series B) on January 13, 2022.
  • Philanthropi raised $4M (Seed) on December 15, 2021.
  • Palos Surgicenter raised $92K (Pre-Seed) on February 18, 2022.
  • Earlitec Diagnostics raised $20M (Funding Round) on February 18, 2022.
  • Earlitec Diagnostics raised $5.5M on February 18, 2022.
  • Tympa Health Technologies raised an undisclosed amount (Seed) on February 17, 2022.

Who to call at Virtue Diagnostics, and when

A new round usually means Virtue Diagnostics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Virtue Diagnostics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Virtue Diagnostics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Virtue Diagnostics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Virtue Diagnostics

Location

Shanghai, Shanghai, China

About

Virtue Diagnostics is an innovative IVD company focused on infectious disease, cancer, and chronic diseases.Our goal is to utilize our diverse technology platforms to provide clinical solutions for patients at all disease stages including early screening, initial diagnosis, treatment monitoring and minimal residual disease management.www.Virtuedx.com

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Virtue Diagnostics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Virtue Diagnostics's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Virtue Diagnostics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.